Maintenance therapies for classic and other forms of bipolar disorder

Journal of Affective Disorders

Volumn 59, Issue SUPPL. 1, 2000, Pages

  Bowden, Charles L ^a   Lecrubier, Yves ^b   Bauer, Mark ^c   Goodwin, Guy ^d   Greil, Waldemar ^e   Sachs, Gary ^f   Von Knorring, Lars ^g  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Mental Health and Behavioral Sciences Service   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e Psychiatrische Privatklinik   (Switzerland)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Carbamazepine; Divalproex sodium; Lithium; Maintenance treatment; Neuroleptics; Rapid cycling bipolar disorder

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CLOZAPINE; INOSITOL; LAMOTRIGINE; LEVOTHYROXINE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; OMEGA 3 FATTY ACID; PLACEBO; RISPERIDONE; THYROID HORMONE; TRANQUILIZER; VALPROATE SEMISODIUM; VALPROIC ACID; VALPROMIDE;

AGRANULOCYTOSIS; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG RESPONSE; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; EXTRAPYRAMIDAL SYMPTOM; HUMAN; MAINTENANCE THERAPY; MANIA; MANIC DEPRESSIVE PSYCHOSIS; NEUROMUSCULAR DISEASE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SUPPLEMENTATION; TREATMENT INDICATION; WEIGHT GAIN;

ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DISEASE PROGRESSION; HUMANS;

EID: 0034468763     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(00)00179-8     Document Type: Conference Paper

References (81)

1. A comparison of in-patient and out-patient prescribing
2. Prophylactic lithium: Double-blind discontinuation in manic-depressive and recurrent-depressive disorders
3. Risks and implications of interrupting maintenance psychotropic drug therapy
4. Rapid cycling bipolar affective disorder. II: Treatment of refractory rapid cycling with high-dose levothyroxine: A preliminary study
5. Testing definitions of dysphoric mania and hypomania: Prevalence, clinical characteristics and inter-episode stability
6. Carbamazepine versus lithium in prophylaxis of recurrent affective disorders
7. Inositol treatment in psychiatry
8. Long-term prophylactic treatment priorities in bipolar disorder. Abstracts of the XXth Collegium Internationale Neuro-Psychopharmacologicum Congress, September 1997, Vienna, Austria
9. Efficacy of divalproex vs. lithium and placebo in the treatment of mania
10. Maintenance clinical trials in bipolar disorder: Design implications of the divalproex-lithium-placebo study
11. Clozapine in treatment refractory mania
12. Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder
13. A medication algorithm for treatment of bipolar rapid cycling?
14. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression
15. Prophylactic lithium in affective disorders
16. Double-blind and open prospective studies of lithium prophylaxis in affective disorders
17. Does lithium reduce the mortality of recurrent mood disorders?
18. The likelihood of recurrence in bipolar affective disorder: The importance of episode recency
19. Lithium and recurrence in a long-term follow-up of bipolar affective disorder
20. A controlled evaluation of lithium prophylaxis in affective disorders
21. Valproate prophylaxis in a prospective clinical trial of refractory bipolar disorder
22. Does maintenance lithium therapy prevent recurrences of mania under ordinary clinical conditions?
23. Clinical factors in lithium prophylactic failure
24. Depression and suicide: Are they preventable?
25. Outcome after rapid vs. gradual discontinuation of lithium treatment in bipolar disorders
26. Long-term response to carbamazepine: A retrospective study
27. Long-term risperidone treatment in bipolar disorder: 6-Month follow up
28. Relapse and impairment in bipolar disorder
29. Predictors of interepisode symptoms of relapse in affective disorder patients treated with lithium carbonate
30. Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder
31. Lithium versus carbamazepine in the maintenance treatment of bipolar disorders - A randomized study
32. Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder
33. Suicide and primary affective disorders
34. Outcome in manic disorders: A naturalistic follow-up study
35. Bupropion as a promising approach to rapid cycling bipolar II patients
36. Practice guideline for the treatment of patients with bipolar disorder
37. Tardive dyskinesia: Prevalence and risk factors
38. Outcome in the pharmacologic treatment of bipolar disorder
39. Secondary mania: Manic syndromes associated with antecedent physical illness or drugs
40. Course of the manic-depressive cycle and changes caused by treatment
41. Comparative study of valpromide versus lithium as prophylactic treatment in affective disorders
42. Carbamazepine vs. lithium in the treatment and prophylaxis of mania
43. Long-term outcome of lithium prophylaxis in bipolar patients
44. Validity of rapid cycling as a course specifier for bipolar disorder
45. Long-term outcome of lithium prophylaxis in bipolar disorder: A 5-year prospective study of 402 patients at a lithium clinic
46. Efficacy of lithium prophylaxis in clinical practice
47. Manic-depressive illness, II: Treatment outcome in bipolar disorder subtypes
48. Prophylactic lithium: A double-blind trial in recurrent affective disorders
49. Lithium revisited. A re-examination of the placebo-controlled trials of lithium prophylaxis in manic-depressive disorder
50. Reduced mortality of manic-depressive patients in long-term lithium treatment: An international collaborative study by IGSLI
51. The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizoaffective illness
52. Outcome of bipolar disorder on long-term treatment with lithium
53. Effects of carbamazepine and lithium on affective disorders
54. A preliminary double-blind study of the efficacy of carbamazepine in prophylaxis of manic depressive illness
55. Lithium prophylaxis of bipolar illness: The value of combination treatment
56. Continuation ECT: Relapse prevention in affective disorders
57. The comparative efficacy and safety of carbamazepine versus lithium: A randomized, double-blind 3-year trial in 83 patients
58. Carbamazepine prophylaxis in refractory affective disorders: A focus on long-term follow-up
59. Alternatives to lithium for preventive treatment of bipolar disorder
60. NIMH workshop report on treatment of bipolar disorder
61. Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group
62. Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness
63. Valproic acid amid as a prophylactic agent in affective and schizo-affective disorders
64. Use of clonazepam for bipolar affective disorder
65. Problems of lithium prophylaxis: Efficacy, serum lithium, selection of patients
66. Lithium prophylaxis: Myths and realities
67. The combat of non-compliance during prophylactic lithium treatment
68. Polypharmacy in bipolar I disorder
69. Lithium plus valproate as maintenance polypharmacy for patients with bipolar I disorder: A review
70. The use of lithium in affective disorders: III: A double blind study of prophylaxis in bipolar illness
71. Lithium-associated cognitive and functional deficits reduced by a switch to divalproex sodium: A case series
72. Omega 3 fatty acids in bipolar disorder: A preliminary double-blind, placebo-controlled trial
73. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder
74. Outcome in mania: A 4-year prospective follow-up of 75 patients utilizing survival analysis
75. Effect of lithium maintenance on suicidal behavior in major mood disorders
76. Maintenance ECT in intractable manic-depressive disorders
77. Outcome of lithium prophylaxis: A prospective follow-up of affective disorder patients assigned to high and low serum lithium levels
78. The effect of carbamazepine and lithium on remission from affective illness
79. Excess mortality of bipolar and unipolar manic-depressive patients
80. Rapid cycling affective disorder: Contributing factors and treatment responses in 51 patients